K. David Voduc

1.7k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

K. David Voduc is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, K. David Voduc has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in K. David Voduc's work include Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (2 papers) and Breast Lesions and Carcinomas (2 papers). K. David Voduc is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (2 papers) and Breast Lesions and Carcinomas (2 papers). K. David Voduc collaborates with scholars based in Canada, United States and United Kingdom. K. David Voduc's co-authors include Torsten O. Nielsen, Maggie C.U. Cheang, Scott Tyldesley, Hagen F. Kennecke, Karen Gelmon, Charles M. Perou, Mark N. Levine, Kathleen I. Pritchard, Inge J. Stijleman and Samuel Leung and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

K. David Voduc

8 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breast Cancer Subtypes and the Risk of Local and Regional Relapse

2010 960 citations K. David Voduc, Maggie C.U. Cheang et al. Journal of Clinical Oncology profile →

Peers

K. David Voduc

CR

ONCOL

PFM

MB

PRM

Hans Halfwerk Netherlands

R.F. Abi Raad United States

Alessandra Balduzzi Italy

M. Piccart-Gebhart Belgium

Svjetlana Mohrmann Germany

Michelle A. Gadd United States

Sandra A. O’Toole Australia

Gabriel Zanón Spain

Rabiul Islam United States

Carmen Say United States

Hans Halfwerk Netherlands

K. David Voduc

787 ×1.0

CR

525 ×0.8

ONCOL

232 ×0.8

PFM

553 ×1.9

MB

158 ×0.9

PRM

Citations per year, relative to K. David Voduc K. David Voduc (= 1×) peers Hans Halfwerk

Countries citing papers authored by K. David Voduc

Since Specialization

Citations

This map shows the geographic impact of K. David Voduc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. David Voduc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. David Voduc more than expected).

Fields of papers citing papers by K. David Voduc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. David Voduc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. David Voduc. The network helps show where K. David Voduc may publish in the future.

Co-authorship network of co-authors of K. David Voduc

This figure shows the co-authorship network connecting the top 25 collaborators of K. David Voduc. A scholar is included among the top collaborators of K. David Voduc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. David Voduc. K. David Voduc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Whelan, Timothy J., Sally Smith, Torsten O. Nielsen, et al.. (2022). LUMINA: A prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T₁N₀ luminal A breast cancer (BC).. Journal of Clinical Oncology. 40(17_suppl). LBA501–LBA501. 31 indexed citations

2.

Lalani, Nafisha, K. David Voduc, Rachel Jimenez, et al.. (2020). Breast Cancer Molecular Subtype as a Predictor of Radiation Therapy Fractionation Sensitivity. International Journal of Radiation Oncology*Biology*Physics. 109(1). 281–287. 12 indexed citations

3.

Asleh, Karama, et al.. (2017). Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up. Breast Cancer Research and Treatment. 168(1). 107–115. 13 indexed citations

4.

Voduc, K. David, Torsten O. Nielsen, Charles M. Perou, et al.. (2015). αB-crystallin expression in breast cancer is associated with brain metastasis. npj Breast Cancer. 1(1). 28 indexed citations

5.

Cheang, Maggie C.U., K. David Voduc, Dongsheng Tu, et al.. (2012). Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial. Clinical Cancer Research. 18(8). 2402–2412. 105 indexed citations

6.

Voduc, K. David, Maggie C.U. Cheang, Scott Tyldesley, et al.. (2010). Breast Cancer Subtypes and the Risk of Local and Regional Relapse. Journal of Clinical Oncology. 28(10). 1684–1691. 960 indexed citations breakdown →

7.

Voduc, K. David, et al.. (2004). Risk of radiation pneumonitis in breast cancer patients treated with adjuvant taxanes and radiation. Journal of Clinical Oncology. 22(14_suppl). 624–624. 10 indexed citations

8.

Voduc, K. David, Scott Tyldesley, & Stephen Chia. (2004). Risk of radiation pneumonitis in breast cancer patients treated with adjuvant taxanes and radiation. Journal of Clinical Oncology. 22(14_suppl). 624–624. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact